Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...

A first-of-its-kind Canadian trial is testing psilocybin, the psychedelic component found in magic mushrooms, on participants ...

Much of the evidence documenting the earliest use of psilocybin in mushrooms for medicinal purposes by the ancient Mayans and Aztecs was destroyed by Spanish missionaries in the 1500s. However, that ...

Reasons to be Cheerful reports on the growing use of psilocybin in mental health treatment, showing promise for conditions like depression and OCD.

According to results of a phase 2 study of PSX-001, the psilocybin-assisted treatment for generalized anxiety disorder led to ...

The Kingston Health Sciences Centre Research Institute launched the first-ever Health Canada-approved clinical trial ...

Kingston Health Sciences Centre is looking for participants for a new study examining how psilocybin the active ingredient in magic mushrooms could help treat anxiety. The two month study will test ...

A new study reports that a single dose of psilocybin, quieted chronic pain and depression-like behavior within 24 hours.

A peer-reviewed viewpoint article published in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic ...

BEND, Ore. (KTVZ) -- A Bend-based therapy group says a single dose of psilocybin mushrooms could lead to lasting mental health improvements, based on what they call the largest study of its kind in ...

Anecdotal reports have suggested that magic mushrooms can have a stronger intensity and different visual effects than ...